Cagrilintide Benefits
Clinical Trials GLP-1 / Weight Loss
Written by Alejandro Reyes
Founder & Lead Researcher
PN
Reviewed by Peptide Nerds Editorial · Updated April 2026
Not medical advice. This content is for educational purposes only. Consult a healthcare provider before starting any peptide protocol. Full disclaimer.
How Cagrilintide works
Mimics the hormone amylin, which is co-secreted with insulin. Reduces appetite through hypothalamic signaling and slows gastric emptying via a pathway independent of GLP-1.
Reported benefits
Based on available research data, Cagrilintide has been associated with the following benefits:
- Complementary mechanism to GLP-1 agonists
- CagriSema combination shows greater weight loss than semaglutide alone
Important context
Benefits reported in clinical trials represent average outcomes across study populations. Individual results vary based on genetics, dosage, duration, and lifestyle factors.
Related peptides
Free Peptide Weight Loss Guide
Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.